quences of the putative ligand-binding domain of the The human TR2 orphan receptor (TR2) is a member TR2 show low homology (10%) with known receptors. of the steroid/thyroid hormone receptor superfamily In addition, the TR2 mRNA has been detected in that regulates the transcription of complex gene net-many rat tissues with the highest abundance in male works and subsequently controls diverse aspects of reproductive organs, such as ventral prostate, semigrowth, development, and differentiation. In the pres-nal vesical, and testis (1). Interestingly, the expresent study, we have found that the TR2 is one of the M1 sion of the TR2 mRNA is negatively regulated by an- actions, protein-protein interactions, and the protein lar permutation assay revealed a localized DNA flexibility induced by the TR2 binding, and the bend angle environment (6). First, protein-DNA interactions are was estimated to be 73 { 2Њ. Furthermore, a dual-lucif-mediated by the highly conserved DNA-binding domain erase reporter gene assay demonstrated that the TR2 that defines the steroid receptor superfamily. The momay enhance the expression of luciferase activities via lecular specificity of the steroid/thyroid hormone recepthe wild-type M1 site but not the mutant M1 element tors is achieved through their selective interaction with in human QM7 muscle myoblasts. In conclusion, our hormone response elements (HREs), which are strucdata represent the first case of demonstrating that the turally related but functionally distinct. The TR2, con-TR2 may serve as a transcriptional inducer in muscle-taining the EGCKG amino acid sequence in the proxispecific aldolase A gene expression. ᭧ 1997 Academic Press mal (P) box of the DNA-binding domain, has been grouped into members of the estrogen receptor subfamily, recognizing the hexameric AGGTCA consensus motif (7). Consequently, we have demonstrated that the The human TR2 is one of the first orphan receptors identified that shares structural homology with TR2, serving as a transcriptional repressor, may recogmembers of the steroid/thyroid hormone receptor su-nize two direct repeats of the AGGTCA core consensus perfamily (1, 2). The TR2-11 cDNA encodes a protein motif in several target genes (8, 9, 10) . of 603 amino acid residues with a calculated molecuSecond, protein-protein interactions necessary for lar mass of 67 kilodaltons (kDa). The deduced amino the formation of homo-and/or heterodimers in solution acid sequences of the DNA-binding domain of the are mediated by at least two regions. The first region TR2 show 50-60% homology with other known steroid is a DNA-supported asymmetric dimerization interface receptor members (2-4). However, the amino acid se-located within the DNA-binding domain of the receptors that selectively promote DNA binding to cognate direct repeat HREs (11-13). The second one is the iden-
mal (P) box of the DNA-binding domain, has been grouped into members of the estrogen receptor subfamily, recognizing the hexameric AGGTCA consensus motif (7) . Consequently, we have demonstrated that the The human TR2 is one of the first orphan receptors identified that shares structural homology with TR2, serving as a transcriptional repressor, may recogmembers of the steroid/thyroid hormone receptor su-nize two direct repeats of the AGGTCA core consensus perfamily (1, 2) . The TR2-11 cDNA encodes a protein motif in several target genes (8, 9, 10) . of 603 amino acid residues with a calculated molecuSecond, protein-protein interactions necessary for lar mass of 67 kilodaltons (kDa). The deduced amino the formation of homo-and/or heterodimers in solution acid sequences of the DNA-binding domain of the are mediated by at least two regions. The first region TR2 show 50-60% homology with other known steroid is a DNA-supported asymmetric dimerization interface receptor members (2) (3) (4) . However, the amino acid se-located within the DNA-binding domain of the receptors that selectively promote DNA binding to cognate direct repeat HREs (11-13). The second one is the iden-nation of this obligatory I box and an optional dimerization interface of the DNA-binding domain increases the diversity of the heterodimeric interaction and high-affinity DNA binding. Third, the protein environment indicates that, aside from the receptor and the DNA themselves, additional roid/thyroid hormone receptors for recognition of their Numbers under the sequence show the aldolase A gene nucleotide target genes (6) . For example, ligand specificity is one residues and the relative 5 flanking sequence from the transcripof the key parameters contributing to DNA-binding and tional initiation site of the pM promoter, respectively (26). dimerization. Studies of thyroid receptor (T 3 R) and RXRs suggest that their respective ligands may affect the formation of dimerization and diversity of function transcribed and translated directly by the TNT system (Promega) (15, 16) . Furthermore, nuclear accessory factors are for EMSA as previously described (8) . thought to serve as bridging molecules or adaptors beCircular permutation assay. Circular permutation assay was cartween the steroid hormone receptors and the basal ried out as previously described (29) . Generally, circularly permutranscriptional machinery (17, 18) . tated DNA fragments were isolated by restriction enzyme digestion of pBend-M1, and purified by electrophoresis on a 1% agarose gel.
Fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) iso-DNA fragments were radiolabeled by a-[ enzymes (type A in muscle, type B in liver, and type C with a random primed DNA labeling kit according to the manufacturin brain) are a family with tissue-specific control of er's instructions (Boehringer Mannheim). EMSA was then conducted gene expression (19). The human aldolase A gene is essentially as described above. For the determination of bend angles, the angle of curvature induced in the DNA by protein binding was transcribed from at least three different promoters, pN, calculated using the empirical equation as previously described (30).
pM, and pH, generating mRNAs with a common coding Thus, the equation is mM/mE Å cos(a/2), where a displays the bending sequence but different 5 flanking regions (19-24). In angle induced by the protein binding. mM and mE correspond to the transgenic mice, both pN and pH promoters are active electrophoretic mobility for the protein-DNA complexes when the in many tissues, while the pM promoter is restricted binding site is at the middle and at the end of the DNA fragment, respectively.
to adult muscles composed mainly of fast-twitch fibers (25). Recently, a minimal pM promoter has been deCell culture and transfection experiments. The human QM7 muscle myoblast cells (American Type Culture Collection, CRL-1962) fined that consists of two important DNA elements (26).
were cultured in Dulbecco's modified Eagle's medium (Life TechnoloThe first binding site (MEF2/NF1) is for myocyte engies) supplemented with penicillin (100 units/ml), streptomycin (100 hancer factor-2 (MEF2) members and NF1 factors. mg/ml), amphotericin (0.25 mg/ml), and 15% heat-inactivated (56 ЊC However, the second one (M1) is for unknown proteins. for 30 min) fetal bovine serum (Harlan). Transient transfection of Surprisingly, this M1 site contains two direct-repeats the QM7 cells plated at an initial density of 3 1 10 5 /60-mm dish was carried out by the calcium phosphate precipitation method in the of the AGGTCA consensus motif spacing with one basepresence of 15% fetal bovine serum or charcoal-treated serum (CTS) pair (bp), referred to as a DR1 sequence. Based on our as described previously (8, (31) (32) (33) . Dual-luciferase reporter assay sysprevious data, we strongly suspected that the TR2 tem was conducted according to the manufacturer's instructions could be one of the unknown proteins which may bind (Promega). The pRL-TK plasmid (Promega) was co-transfected to to this M1 site and influence the tissue-specific gene normalize the transfection efficiency. expression of the pM promoter. Hence, we explored the specific interaction between the M1 site and the TR2. RESULTS Moreover, the possible consequences of tissue-specific expression via protein-DNA binding in the human QM7
Binding of the human TR2 to the M1 site of the pM promoter of the aldolase A gene. To test if the TR2 muscle myoblasts were analyzed.
could be one of the unknown proteins regulating the MATERIALS AND METHODS tissue-specific gene expression of the aldolase gene, we applied EMSA to reveal the specific interaction bePlasmid construction. Plasmid pSG5-TR2 contains the fulltween the TR2 and the M1 site. As illustrated in Fig.  length coding sequence of the human TR2 cDNA in the pSG5 vector 1, the TR2 and several orphan receptors were ex-(Stratagene) under the control of both SV40 and T7 promoters for pressed in a coupled in vitro transcription-translation in vivo and in vitro expression, respectively (8, 10) . Plasmids pCMXRXRa and pT7hmSHP were kindly provided by Drs. Ronald M. Ev-system ( Fig. 2A) . The TR2 was expressed as a protein ans and Wongi Seol, respectively (27, 28) . Plasmids pGL3-M1 and with a molecular mass of 67 kDa (lane 1), while the pGL3-mM1 consist of one copy of the wild-type M1 site corresponding mock-translated control produced no detectable prod- containing the full-length TR2, RXRa and SHP cDNAs were in vitro SHP orphan receptors were also generated in vitro for ized in EMSA (Fig. 2B, lane 3, arrowhead) , and could be abolished in the presence of 100-fold molar excesses of unlabeled oligonucleotides (lane 4). In addition, the polyclonal anti-TR2 antibody could supershift this specific DNA-protein complex (lane 6, arrow). However, the monoclonal anti-TR2 antibody might eliminate this complex (lane 7). These data demonstrated that the TR2 can specifically bind and form a single complex with the M1 site of the aldolase A gene.
To further determine the DNA-protein binding affinity between the TR2 and the M1 site, Scatchard binding analysis was conducted by the EMSA as shown in Fig.  3 . Constant amounts of the in vitro expressed TR2 (5 ml) were incubated with different concentrations of the DNA probe (0.2-6.4 ng). Specific DNA-protein complexes were resolved in EMSA (Fig. 3A, arrowhead) . Scatchard analysis resulted in a single binding component for the DNA-protein complex with a dissociation constant (K d ) of 4.6 nM and B max of 0.03 nM (Fig. 3B) . These data fit well into the range of K d for classical steroid receptors with their HREs, suggesting that the TR2 can bind to the M1 site with high affinity.
Lack of indication that the TR2 forms heterodimers with other partners.
To reveal whether the TR2 might form heterodimers with either RXRa or SHP by protein-protein interaction, we employed in vitro expression ( Fig. 2A) and EMSA in the presence of the M1 element (Fig. 4) . A specific DNA-protein complex was seen, as before, between the TR2 and the probe (Fig.  4, arrowhead) . In contrast, both RXR and SHP do not interact with the M1 site (lanes 4 and 5). Moreover, we detected the original DNA-protein complexes only of the aldolase A gene were positioned near the center of two tandemly repeated copies of a polylinker sequence in the pBend5 plasmid. Digestion of the relater study (lanes 3 and 4) . Using EMSA, the potential interaction of the TR2 with the M1 site of the aldolase sulting plasmid, pBend-M1, with a number of restriction enzymes yielded a set of DNA fragments with al-A gene was revealed as shown in Fig. 2B . Doublestranded oligonucleotides corresponding to nucleotide most identical length but containing the M1 site at different positions (Fig. 5A ). Each DNA fragment was numbers 2017-2034 of the aldolase A gene were labeled as a probe. A specific DNA-protein complex was visual-incubated with either mock-translated product or the tion with the M1 site, we performed a dual-luciferase reporter assay in human QM7 muscle myoblast cells. As shown in Fig. 6 , QM7 myoblasts were co-transfected with increasing amounts of mammalian expression vector containing full-length TR2 cDNA (pSG5-TR2) and one of three reporter plasmids (the parent pGL3-promoter, pGL3-M1, and pGL3-mM1). The results showed that the TR2 can trigger the luciferase reporter activity only via the wild-type M1 element in a dosedependent manner. This indicated that the TR2 can enhance aldolase A gene expression via the interaction between the TR2 and the M1 site of the pM promoter.
DISCUSSION
The human aldolase A gene identified in the present study may represent the first induced target for the TR2. We have previously demonstrated that the TR2 may repress the gene expression of several targets, including the human erythropoietin gene, SV40 major late promoter, and RAR/RXR signal pathways, respectively (8, 9, 10) . However, the data in this report demonstrated that the TR2 can also function as an inducer to induce its target gene. The ability and behavior of the TR2 are, therefore, in good concert with other orphan receptors, like the COUP-TFs and RXRs (4, 6). Thus, various superfamily members recognize and function differentially in complex networks of gene-specific regulation.
The TR2 may be one of candidates to bind to the M1 site of the pM promoter of the aldolase A gene and regulate the tissue-specific gene expression. According to data from previous studies, the minimal pM promoter contains at least two important DNA elements TR2 to form complexes resolved in a 5% nondenaturing gel (Fig. 5B) . Figure 5C shows that the relative mobility was plotted against the position of the recognition sequence within the DNA fragment. The result revealed a DNA bending can be induced by the binding of the role in the aldolase A gene expression via the interac-RXRs, may play a role via the M1 site of the aldolase A gene. These orphan receptors are able to bind to DR1 sequences and regulate their targets (6, 27) . In addition, it is very likely that several M1 binding proteins can integrate and coordinate with this element of the pM promoter to regulate the aldolase A gene in physiological conditions. These M1 binding proteins may act alone or interact with one another to yield additional or synergistic effect.
Basically, members of the steroid/thyroid hormone receptor superfamily are capable of binding to their DNA response elements in three different ways, homodimeric, heterodimeric, and monodimeric categories (4, 6). The NGFI-B/TR3 orphan receptor is a classical example for the monomeric subfamily members that bind to a single copy of the core motif proceeded by an ATrich sequence, referred to as a NGFI-B response element (NBRE) (35-37). The M1 site of the pM promoter in the aldolase A gene contains a DR1 sequence as we indicated in Fig. 1 . Indeed, the first repeat of the core motif corresponding to nucleotide numbers 2017-2025 consists of a NBRE-like sequence. We suspected that this NBRE-like motif may contribute to the recognition for the TR2 during tissue-specific regulation. Therefore, the NBRE-like oligonucleotides were synthesized and tested for the recognition by the TR2 using EMSA (34) . This implies that the M1 site the M1 site by dual-luciferase reporter assay. Human QM7 muscle is indeed needed in order to fulfill the muscle-specific myoblast cells were co-transfected with increasing amounts of the enhancer and promoter activities. However, we do be-pSG5-TR2 expression plasmid (lanes 2, 3, 5, 6, 8, and 9) and the parent pGL3-promoter (lanes 1-3) , pGL3-M1 (lanes 4-6), or pGL3-lieve that the TR2 may represent one of the M1 binding mM1 (lanes 7-9) reporter plasmid. All firefly luciferase activities were proteins. It will not be a surprise, if other receptors or normalized with Renilla luciferase activities and then averaged over proteins are also capable of binding to this M1 site, at least four independent experiments with error bars designating and differentially regulating on this region. Especially, standard deviations. Significant (p õ 0.05) differences from control (lane 1) are marked with asterisks.
orphan receptors, such as COUP-TFs, HNF4, TR4, and able to identify new response systems that may have valuable biological and physiological implications. Thereby, we may reveal the association of this orphan receptor in different physiological pathways, which may ultimately lead to the discovery of its ligand specificity and physiological functions.
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FIG. 7.
Model for the TR2-induced DNA bending. The TR2 is
